Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What a fantastic day. Congrats to longs. 13d shills can eat crow.
Absolutely lovely. They are unethical at best but wouldn't be surprised if they broke any laws.
Is it documented that they brought in a securities specialist?
Most creative excuse I heard from a troll on ECOR is that the company was overpriced so the 95% decrease is just an adjustment to fair market value. Great reason to bring Errico over to run our company.
These 13Ds are as sleazy as they come. They should get into politics. Oh wait Rosenbaum had a few stints in politics. Must be where he got his sleazebag training.
.
Pretty benign compared to what Rosenbaum did to a former SWR employee.
https://casetext.com/case/lepine-v-rosenbaum
Amazing! Wish him speedy full recovery!
Truly sad to hear what you and your Family is going through. I know your son is as resilient as mom and pray for him to get well soon.
I'd like to see 13d draw the "go to jail card". Glad we're rid of the sideshow and can continue with business.
From reddit:
Summation of DD:
The DOJ action was not seen as material to disclose outside of the 10K. Arian Colachis said, no one in the company is shorting the stock.
Paul Rosenscam resides in Oregon.
What seems to be orchestrated hit pieces from (PAUL) Oregon:
July 30th (date of 10K to promote FUD):
Lies about what the FDA SAID: “statistically insignificant”
What the 10K actually said:
“In closing, FDA stated that subgroup analyses may inform the design of future clinical trials investigating leronlimab for the treatment of COVID-19.”
“Preliminary results from the trial suggested leronlimab improved a majority of clinical symptoms with a Top-line Report expected to be issued AFTER this filing.”
Proxy:
Board meeting can be postponed and will be if they need to. But
the confidence of CytoDyns 8K tells ME something BIG is coming.
I don’t think there will even be a proxy vote. Key words from 10K: “potential proxy”
Furthermore:
The same Oregon article above actually linked the May 18th hit piece about The FDA statement. Why would someone who wants to accelerate LL pay for that article?
My question is why do these hit pieces all revolve around things that could be manipulated or influenced? Didn’t the 13D crew insinuate or say they had friends in the FDA?
Phantom Lawsuits:
IncellDx is near GILD world head quarters. Those law firms are around 13Ds residencies or even around 13Ds proxy consultants.
Competition doesn’t concern me:
“Maraviroc, like all other HIV approved drugs, must be taken daily and is believed to have side effects and toxicity.”
The CytoDyn -Jonah Sacha- formula for 1-3 month treatment seems to be going well.
What stood out to me for RO Assay was this:
“Importantly, and in parallel with the submission of our pivotal trial protocol for monotherapy, we recently announced the completion of the development of >>A<< receptor occupancy assay to measure the expression of CCR5 in HIV and tumor cells that are occupied by leronlimab.
Provisions:
“provisions could prevent or frustrate attempts by our stockholders to replace or remove members of our Board.”
Cash:
They focus on cash at hand (35M).
but not that our CRO is PREPAID, and that our trials overseas are cost effective. A faster enrollment bonus of (younger) and (likely) high CCR5 expressive patients are going to be expedited for 40% interim analysis.
SEC is done:
“The SEC has informed the Company that this inquiry should not be construed as an indication that any violations of law have occurred or that the SEC has any negative opinion of any person, entity or securities trading activity.”
Coming soon:
LH topline and Brazil trials.
Insider buying in August window is open.
Possible Cancer and NASH BTD.
Personally, I can’t ever vote for Paul when he sexually harassed a female and then wants control over MTNBC.
I can’t vote for Dr. Burglar Pattent for taking IP under NDA and withholding data.
I can’t vote for The group when Beaty / Errico collectively dump on positive Press Releases. Or when Beaty bought several 10K lots around the time “TI” on YMB claimed were all institutional buys, and suddenly TI supports 13D and Beaty later dumps during the Citron article hit piece.
To end this positively: have you read the LH article CytoDyn posted?
The trials involving LH include
“stretching and massage” “probiotics” “melatonin”
It’s all about il6; gut and inflammation,and we know that t-cells are “potentially” blocked from forming inflammation and patients slept better.
I hypothesize (not a doctor or scientist) that the Diarrhea SE for some patients is actually cleaning out the patient similar to a hydro therapy colon cleanse. With less “SIBO” (small intestinal Bacteria Overgrowth) the body will function better.
What I believe happening to the body is Carbs (for LH sufferers) are not turning into ATP, rather they’re staying in the pyruvate state and turning into what we know as “Lactic Acid” (Lactate). Unfortunately, when we eat, the SIBO is eating our nutrients and we get weaker, causing inflammation, ammonia (causing fog brain) etc.
With high levels of Lactic Acid comes “High anion gap metabolic acidosis (HAGMA)” it ultimately causes Hypoxia (lack of O2 in body) resulting in possible, Sepsis, multiple Organ Failure, shock, CHF, diabetes, and LIVER disease.
Once Recknor finds specific details on MOA of LL, I believe he uncovers everything inflammatory related.
It will be glorious if it gets traced back to 13d.
Reads like a paid ad by 13d. Won't fool shareholders.
13d pulling out all the stops now. It's almost game day and they don't have a plan. Only attacks on management.
Snippet 1 from Cytodyn Shareholder Community Group on FB:
DATE: JULY 28, 2021
TO: THE PAUL ROSENBAUM GROUP
(Name of Registrant as Specified in Its Charter)
PAUL A. ROSENBAUM
JEFFREY P. BEATY
ARTHUR L. WILMES
THOMAS J. ERRICO, M.D.
BRUCE PATTERSON, M.D.
PETER STAATS, M.D., MBA
MELISSA YEAGER
CCTV PROXY GROUP, LLC
FROM: CONCERNED SHAREHOLDERS
SUBJECT: POTENTIAL FAILURE TO DISCLOSE MATERIAL INFORMATION
The Schedule 13D must be filed within 10 days after the acquisition and must include certain key information, including the purpose of the acquisition. Specifically, Item 4 of Schedule 13D requires the filer to describe any proposals which relate to, among other things, (a) an extraordinary corporate transaction involving the issuer, such as a merger, (b) a sale of a material amount of assets of the issuer, (c) any change to the board of directors of the issuer and (d) any other material change to the issuer’s business or corporate structure.
Shareholders are concerned that the filings to date (13D, 14A) submitted by The Paul Rosenbaum Group (GROUP) to the SEC may contain numerous omissions and, therefore, present material misrepresentations of facts based on prior discussions, communications and commitments made to shareholders and others. NOTE: WE DO NOT KNOW OF, NOR ARE WE MAKING ANY ASSUMPTIONS OF, ANY WRONGDOING OR IMPROPER ACTIONS OR INACTIONS OF THE GROUP. WE SIMPLY WANT TO UNDERSTAND THE GROUP’S PLAN SO THAT SHAREHOLDERDS CAN BE INFORMED.
Please see the following References:
(1) Numerous emails and phone conversations with select shareholders occurring between March 1, 2021 – June 30, 2021.
(2) The Zoom conference call presentation and discussion by Paul Rosenbaum, Bruce Patterson, and others to discuss their plan for taking over the company. This Zoom meeting was held on May 6, 2021.
(3) Zoom Follow Up email from Paul Rosenbaum dated May 6, 2021:
---------- Forwarded message ---------
From: Paul R
Date: Thu, May 6, 2021 at 8:52 PM
Subject: Please make checks payable to CCTV ( Cytodyn Committee to Victory) for $7500
To:
To All:
Thanks for today. I think it was a productive meeting.
As I mentioned before, the checks will not be deposited in an account until we reach our stated goals both for funds needed, and shares required.
I must receive the checks immediately in order to meet our filing requirements
Please call if you have any additional questions
Thanking you in advance for your cooperation
Paul R
Make checks payable to CCTV for $7500.
Paul Rosenbaum
2945 NW Luray Terrace
Portland Oregon 97210
(4) Paul Rosenbaum’s letter of Concern to CytoDyn’s Board of Directors, specifically Section BASIS FOR SHAREHOLDER CONCERN, paragraph 3, which reads as follows:
3. Dismissal of Highly Credible Clinical Partners. There is no doubt that the research and public presentations by IncellDx and Bruce Patterson, MD, have raised CYDY’s public profile and increased its credibility. The circumstances surrounding the breakdown of the relationship between CYDY and IncellDx remain murky, but the results of the breakdown are apparent. IncellDx was a material source of scientific direction and Mechanism of Action (MOA) definition for CYDY. The elimination of this relationship appears to have resulted in a reduced understanding of how Leronlimab works and where drug development research should be focused.
(5) Letter to Dr. Pourhassan from Paul Rosenbaum and other shareholders representing over 175MM shares of stock. See Attachment #1: Letter to Dr. Pourhassan for the complete contents of the letter.
Excerpts:
…we are writing you on behalf of CytoDyn shareholders representing over 175MM shares of common stock and growing.
…The signatures below represent only a portion of the commitment to this position.
…Please do not underestimate our dedication to what is in the best interest of the shareholders.
…An IncellDx investor informed us that IncellDx was NOT involved in the combination therapy trial, and only became involved in the later stages of the mono-therapy trial.
…IncellDx has been leading the way in long hauler research and treatment. We have third party opinions that the IncellDx quantitative CCR5 IHC assay with a scoring system that can be followed, is far superior to what is available on the market today for CCR5 IHC.
From APL on ymb
I think today is a good day to post this again. Day 63. Still no 13D plan. This could be why:
Interesting info from another board. There is a pattern here. Prostagene acquired because it had a great test kit. Which turned out to be not true. Now, 13D's are enamored with IncellDx, because Dr. P. has a great test kit. Carraciola, a former Gilead VP, is one of the common threads here. Follow the dots. 2012 cytodyn buys pro140, Nader is ceo at that time. 2013 Tony C is named chairman of board.
Jan 2017 Tony named executive chairman, effectively replacing Nader. Google "what does an executive Chairman of the Board do?" Nader is still ceo but Tony is in charge of planning, business dev. And operations.
Aug 2018 cytodyn agrees to buy Prostagene. Pestell becomes CMO. Strategic Initiatives like acquisitions are one of responsibilities of an executive chairman. Tony C. resigns his role as executive chairman after the agreement to acquire Prostagene is made and becomes just the chairman. Pestell joins the BoD Nov 2018. July 2019, Pestell is fired for cause. In August Pestell sues cytodyn.
In Aug 2019 cytodyn has meeting with fda to discuss Prostagene's test kit. Following the meeting, it becomes clear the investment to secure 510(K) approval would be substantial. The test kit that was "ready for market" just isn't.
Dec 2018, Tony C. was replaced by Scott Kelly as cob.
April 2020 the original BLA for combo was filed
May of 2020 is when the fda had some problem with it
July 2020 is when we got the RTF. Dr. P. dropped shortly after that. All these people are key players in the 13d group. Any chance of replacing the Nader mgmnt team and bod is counting on the ignorance of retail investors to this info. Based on the past it seems Tony, Pestell and Bruce are all in it for personal enrichment. The first thing the 13d group wants to do is buy IncellDx, at SH expense, enriching Bruce and his investors. Just like what Tony did for Pestell. Nader has tried to navigate these expensive distractions by focusing on getting leronlimab through trials, raising money to pay for it and getting distribution deals. This is as plain as I can make it, don’t listen to this group's attempt to make everything a Nader problem, it is their doing from all the way back in 2017 when Tony, an ex gilead VP, became Executive CoB.
Based on this history, it doesn't appear to be a coincidence that the ECOR approval secured by Drs. Errico and Staats was a 510(K) approval. So the apparent plan is to have SH's pay for acquiring IncellDx through a dilutive offering, enriching themselves and then spending even more money pushing to secure a 510(K) approval for IncellDx test kits, which could take years, while putting leronlimab on the back burner or selling it out for pennies on the dollar, which helps.... wait for it.... Big Pharma. And this time, the cost for the acquisition won't be $15.4M. It will probably be closer to $150M. And now that I think about it, what is to prevent them from making a play to merge ECOR into CYDY? And they could do this prior to selecting new executive officers by appointing Mr. Rosenbaum as Executive Chairman. With Drs. Patterson, Errico, and Staats sitting on the board, this would be the ultimate in self dealing. Do your DD. Follow the dots. Don't trust what you don't know. The 13D's have shared nothing pertinent with you. Retail investors have tools
available today that never existed before. Which allowed folks like 13D's to bamboozle uninformed investors in the past. That isn't the case today. As a whole, retail investors the days are much better informed and know where to go in order to triage the truth. We are in the driver's seat. There are alot of back seat drivers telling you that you don't know where you're going and are lost. I know exactly where I'm going, and who has my best interests at heart. #TeamCYDY
Good luck with your complaint. It will go as far as 13d will. No where.
13d has nothing on current management. This group is trying to steal a late stage biotech for self enrichment. New investors next year will never of them.
13d and their affiliates would look great in jumpsuits.
Can't wait for your report! From what we Already know about 13d and how they botched the takeover plan thus far. They don't stand a chance.
From ymb:
Bruce goes on tedtalk…3 days later a patent is filed… something happens between NP and Bruce shortly after. Bruce makes claims that Leronlimab goes “viral load to Zero by 14 days”, when in fact NP never said that. Then the stock goes up to $10.01.
Then, Citron attacks with help from Sykes. During which plenty of the 13D crew sell high and then eventually buy low.
For example: this is just 1 of the Registrants history:
JEFFREY P. BEATY
Beaty sold:
80,000 shares
Rebought- 46,500 shares
The price that day was $10.01 high and low of $5.65
CytoDyn filed for Nasdaq Uplist on July 15th, price $4.92.
Beaty sells 77,714 shares on July 17t, the same day it’s announced Dr. Bean will be hosting NP the next day. Price $5.41
Reminder is sent out January 4th because we begin to get flooded with “phantom lawsuits” for the webcast January 6th, for “regulatory developments, and eua requests for Covid in different countries.”
January 7th (day after webcast) we go from $5.94 down to $5.06 after Beaty sells 190k shares from that day on until April 7th where we then sat at $3.50
This leaves frustration to many people who bought above $4. Then a weird campaign held by Bream who is (an open supporter of spreading rumors) goes on tape and challenges the FDA in a mask happens, and then sells between $3.13 and $2.80
Shortly after the campaign; the fda statement happens, crashing the stock.
Bream, Yo, Patterson start touting Invermectin and Maraviroc when Cydy builds hype in the Philippines, all seem “frustrated” with Leronlimab “not being available.”
They suppressed the Preliminary Long Hauler results pretty well. Since the 13D crew announced their proxy vote we have been steadily going down.
However, now with great cancer results into play, the stock rises from $1.44 to $1.89.
With 2.8 Million shares shorted and 2.2 million still borrowed, the short mafia is down $1Million.
Now tonight, AF is back after the submission of their 14A with a hit piece by a random Twitter account so someone can cover.
Another very interesting parallel of events, @Victru17 points out the 13D partner “Okapi Partners” on Twitter follow, AF, and Citron.
PS: if you haven’t noticed, most of the tweets extremely concerned about the FUD around Bruce and NP that Bruce responds to are from accounts with 0-6 followers.
They want our drug via Proxy vote and they want to cover. I’m buying more votes.
Stronger in numbers! Reddit CYDY board is run by an anti-CYDY mod that is deleting pro-cydy/management posts to control their narrative and spread lies. Sound familiar????
Do not go to original cydy sub-reddit. There are two new cydy subs that you can join that were created by true longs for investors. Please join to show your support and exchange information with other longs that won't be censored.
https://www.reddit.com/r/LeronLimab_Times/
https://www.reddit.com/r/CYDYFacts/
Polling on FB and Yahoo shows overwhelming support for current management. They were pretty close on reddit or might have been a slight beat. I agree that most of the 13d supporters are probably not shareholders so the polling on reddit is likely misleading.
13d is cornered after dropping the slate of nominees and expecting much fanfare but it was a total bust.
By qualified he means bring in two directors that know how to transform a $1b company into a $50m company in 3 years. That type of talent is not easy to come by.
What's with all these accounts created Q2 this year, masquerading as shareholders and endless bashing of NP. Did he just become a bad leader this year?
The 13d plan whenever it comes out will be dead on arrival. They've already lost all credibility with shareholders based on past actions and their true motive is clear as day.
13d support is waning by the second.
Maybe we can hire 13d to throw out the trash full time. They want to be employees of the company. That may be their opportunity.
It has been discussed here and in other platforms that Bruce wanted CYDY to acquire Incelldx for $350m. Now he's partnered up with 13d to go for the whole shebang. There have been posters who attended a 13d call and confirm that acquiring Incelldx is part of the plan if 13d wins the proxy.
I think we can all agree on 13d will acquire or merge with incelldx and/or sell cydy. The sale would be rushed and undervalued. They're accumulating shares on fire sale now and with the shares they'll award themselves. 13d will make out like bandits. This stinks to high heaven.
13d has increased their holdings over this period of time where the stock price has been depressed. There has been unrelenting attacks on cydy during this same period while they've been accumulating shares. I don't think that's a coincidence. Yes the share price is low now and that benefits those that are buying now. They will undoubtedly sell at a higher price and make a healthy profit.
Sounds like electrocore could use some help. Maybe 13d can take over if it doesn't work out here.
Not CNN anchor but check out post.
https://mobile.twitter.com/KarenSueDennis/status/1406778154258206729
Thanks for all the valuable intel. May I copy and post to other platforms?
I'm with you Amber. Can we get NP for a one finger photo. I'll deliver one to Rosenbaum and one to the FDA.
I think they continue to run the smear campaign while trying to gain support until the most opportune time to release their "plan". Could be waiting on a confluence of events to have the most impact, e.g., investor sentiment bottoms out, lower share price, trial delays or negative news, timing the release closer to proxy vote to avoid people from poking holes in their plan. If they put out a plan too soon, they risk cydy accomplishing any number of objectives on their plan prior the vote and losing support.
I firmly believe that is their intention is to depress the share price, destroy management credibility and sway votes in their favor.
I just want say thank you and everyone else here for all that you've done and for being advocates of the company.
From jonboy969 on stocktwits
"for those following what's happening in Brazil, ANVISA has already approved LL as part of the drug registration process and a DCB has been established.
The DCB is the name of the drug or the active pharmaceutical ingredient (API) approved by ANVISA. It is used to standardise the nomenclature of drugs and is essential in a plethora of market access activities such as drug registration, pricing, generics identification etc
https://www.gov.br/anvisa/pt-br/composicao/diretoria-colegiada/reunioes-da-diretoria/votos/2021/copy_of_rop-10.2021/item-2-1-5-e-2-4-28-voto-88-2021-dire2.pdf
The timing isn't coincidental. 13D wants the share price down to support their argument that NP isn't just a bad leader but immoral and a conman. Group may accumulating shares at these prices, we'll find out soon. The ceo smear campaign and lies to harm the company are relentless. I hope we have a poison pill in place.
You are one fiery gal. Thanks for the great read. Check in randomly to see if this company still has a pulse but its officially flatlined. We can call the coroner now and bury it for good. Lost my shirt here back on 2018 and I think most of the longs threw in the towel around that time as well.
You have compiled enough evidence to warrant a frivolous lawsuit. Best to contact the lawyers representing the class action lawsuit to share your findings, if you have enough shares you can be the lead claimant.
Investigate the CEO for a house purchase? Lol
Adding Aug options and will scale in if it price drops. What do you all think is the best option play being we're so close now?
Some people won't be happy regardless of what the share price is. All the Nader haters will still be whining when the share price is $20 and EUA is granted by the Phillipines. I guess they'll all sell when the 13D group doesn't win the proxy fight or continue whine in perpetuity.
Jumped in on auph today. Thanks!
It will be delisted on April 2. Citi is a bunch of crooks.
They didn't give a rats arse about the warrant holders. Hard to have any confidence in the BOD and Dan. Long term shareholders that haven't averaged down are down big time and will get wiped out with a reverse split. Your short strategy is risky but has a good probability of making money.